Showing results (81-90 of 2,254) with videos related to
Sort By:
Pageof 226
Diabetes, Obesity & Metabolism|May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.Journal of Vascular Surgery|February 23, 2020
Population-based long-term outcomes of open versus endovascular aortic repair of ruptured abdominal aortic aneurysmsKonrad Salata, Mohamad A Hussain, Charles de Mestral, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightDeepak L Bhatt, Eric J TopolCleveland Clinic Journal of Medicine|May 23, 2002
The CURE trial: using clopidogrel in acute coronary syndromes without ST-segment elevationGregory P Gerschutz, Deepak L BhattHerz|September 2, 2004
Management of acute coronary syndrome in diabetes mellitusJim M John, Deepak L BhattCurrent Atherosclerosis Reports|March 17, 2004
Inflammation and atherosclerosisMehdi H Shishehbor, Deepak L BhattClinical Cardiology|January 30, 2008
Evolution of anticoagulant and antiplatelet therapy: benefits and risks of contemporary pharmacologic agents and their implications for myonecrosis and bleeding in percutaneous coronary interventionHector M Medina, Deepak L BhattCurrent Treatment Options in Cardiovascular Medicine|March 8, 2008
Treating patients with non-STEMI: stent the culprit artery only or address all lesions?Mehdi H Shishehbor, Deepak L BhattCleveland Clinic Journal of Medicine|February 4, 2010
Omeprazole and clopidogrel: Should clinicians be worried?Jeremiah P Depta, Deepak L BhattCurrent Cardiology Reports|September 28, 2018
Management of Anticoagulation in Patients with Atrial Fibrillation Undergoing PCI: Double or Triple Therapy?Benjamin E Peterson, Deepak L BhattPageof 226